# Influence of the extent of cervical lymph node dissection and lymph nodes metastases on prognosis in a cohort of dogs with oral malignant melanoma treated by surgical resection and adjuvant anti-CSPG4 electrovaccination: a retrospective study on 77 cases

**Authors:** Davide Giacobino, Matteo Olimpo, Erica Ilaria Ferraris, Greta Martinelli, Lorella Maniscalco, Mariateresa Camerino, Federica Riccardo, Federica Cavallo, Lidia Tarone, Marzia Cino, Alfredo Dentini, Selina Iussich, Elena Lardone, Luca Manassero, Raffaella De Maria, Paolo Buracco, Emanuela Morello

PMC · DOI: 10.3389/fvets.2025.1616419 · Frontiers in Veterinary Science · 2025-07-25

## TL;DR

This study examines how lymph node dissection and metastases affect survival in dogs with oral melanoma treated with surgery and electrovaccination.

## Contribution

The study provides new insights into the surgical management of canine oral malignant melanoma by evaluating lymph node dissection approaches and metastasis impact.

## Key findings

- Lymph node metastasis was present in 31% of dogs, primarily in the mandibular lymph center.
- No significant survival differences were found between dogs with or without lymph node metastasis.
- Ipsilateral lymphadenectomy showed no inferior outcomes compared to bilateral dissection.

## Abstract

The most appropriate approach to regional/sentinel lymph nodes (LN) for staging canine oral malignant melanoma (OMM) is still controversial. This study aims to retrospectively evaluate the prognostic impact of neck dissection modality and LN metastasis in a homogeneous cohort of dogs treated by surgery and adjuvant anti-CSPG4 electrovaccination. Seventy-seven dogs were enrolled and divided into two groups based on the presence (Group A, 24 dogs) or absence (Group B, 53 dogs) of histologically confirmed LN metastasis at the time of surgery. The overall LN metastatic rate was 31%; metastasis was found mostly in the mandibular lymph center (83%). Median survival time (MST) and disease-free interval (DFI) in Group A were 406 and 134 days, respectively. Although shorter, these values were not significantly different from MST and DFI in Group B (534 and 219 days, respectively; p = 0.16 and p = 0.11). Stratifying the cases based on the type of lymphadenectomy performed, no statistical differences were observed between Groups 1 (ipsilateral lymphadenectomy) and 2 (bilateral lymphadenectomy) regarding both MST and DFI. Similarly, no significant differences in MST and DFI were observed among subgroups based on ipsilateral (Group 4) and bilateral (Group 6) removal versus ipsilateral (Group 3) and bilateral (Group 5) non-removal of even the medial retropharyngeal LN. No association was found between LN metastasis and recurrence or distant metastasis. Finally, no association was found between lymphadenectomy pattern and progressive disease. The results recorded in this study, i.e., that ipsilateral mandibular lymphadenectomy may be a reasonable surgical option in OMM, apply for this cohort of dogs only, and the translation of this principle to canine OMMs differently treated needs further investigations. Additionally, further efforts should be addressed to studies on sentinel LN identification for canine OMM staging.

## Linked entities

- **Proteins:** CSPG4 (chondroitin sulfate proteoglycan 4)

## Full-text entities

- **Genes:** CSPG4 (chondroitin sulfate proteoglycan 4) [NCBI Gene 487658]
- **Diseases:** OMM (MESH:D008545), LN metastasis (MESH:D008207)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12333538/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12333538/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12333538/full.md

---
Source: https://tomesphere.com/paper/PMC12333538